Agafonova Nataliya's most recent trade in Longeveron Inc - Ordinary Shares - Class A was a trade of 6,120 Class A Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. | 02 Jan 2025 | 6,120 | 151,694 | - | 1.8 | 10,955 | Class A Common Stock |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 01 Oct 2024 | 5,316 | 157,814 | - | 1.9 | 9,994 | Class A Common Stock |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 175,750 | 177,521 | - | 0 | Class A Common Stock | |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 15 Aug 2024 | 14,391 | 163,130 | - | 2.5 | 35,402 | Class A Common Stock |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.83 per share. | 02 May 2024 | 308 | 1,771 | - | 2.8 | 872 | Class A Common Stock |
Longeveron Inc - Ordinary ... | Agafonova Nataliya | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Jan 2024 | 3,074 | 20,786 | - | 1.3 | 4,058 | Common Stock |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.36 per share. | 18 Aug 2023 | 3,081 | 26,919 | - | 3.4 | 10,352 | Common Stock |
Longeveron Inc - Ordinary ... | Nataliya Agafonova | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 30,000 | 30,000 | - | 0 | Common Stock |